A global proteomic analysis revealed unique protein expression patterns in all three genetically distinct meningioma groups AKT1E17K/TRAF7, KLF4K409Q/TRAF7, and NF2−/− when compared to normal meningeal tissue allowing further exploration of these targets for personalised therapy (Fig. 3a). This evidence concerns the gene TRAF7 and meningioma.